Related Experiment Videos
Growth inhibition by homofolate in tumor cells utilizing a high-affinity folate binding protein as a means for folate
1Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
Abstract:
A subline (JT-1) of L1210 mouse leukemia cells that contains elevated levels of a high-affinity folate binding protein is sensitive to growth inhibition by homofolate. Inhibition was observed at nanomolar concentrations of folate or 5-formyltetrahydrofolate where the high-affinity binding protein is the predominant uptake route for folate compounds. At 1.0 nM folate, inhibition of growth by 50% occurred at 0.7 nM homofolate, and maximal inhibition exceeded 90% at homofolate concentrations above 10 nM. Homofolate also inhibited the uptake of 1.0 nM [3H]folate by L1210/JT-1 cells in 72-hr cultures, and the extent of uptake inhibition by 1.0 and 20 nM homofolate was comparable to the inhibition of cell growth by the same concentrations of homofolate. At a growth-limiting concentration of 5-formyltetrahydrofolate (0.5 nM), half-maximal inhibition of L1210/JT-1 cell growth occurred at 1.0 nM homofolate. When excess concentrations of folate (5 microM) or 5-formyltetrahydrofolate (0.5 microM) were added to the medium, no growth inhibition was observed for homofolate at concentrations up to 100 microM. Parental cells lacking the folate binding protein did not respond to homofolate either at growth-limiting (0.5 microM) or excess (5.0 microM) levels of folate. Binding measurements showed that homofolate has a high affinity for the folate-binding protein (Ki = 0.03 nM) but interacts poorly with the reduced-folate transport system (Ki = 203 microM). These results indicate that homofolate inhibits the growth of L1210 cells when intracellular folates are acquired via the high-affinity folate binding protein. The basis for this inhibition appears to be competition by homofolate for substrate binding and internalization.
Insights
Homofolate inhibits L1210 leukemia cell growth by targeting a high-affinity folate binding protein. This folate analog competes for uptake, demonstrating its potential as a targeted therapeutic agent.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- L1210 mouse leukemia cells exhibit varying folate uptake mechanisms.
- A specific subline, JT-1, overexpresses a high-affinity folate binding protein.
- Folate binding proteins are crucial for cellular folate acquisition.
Purpose of the Study:
- To investigate the effect of homofolate on L1210/JT-1 cell growth.
- To determine the role of the high-affinity folate binding protein in homofolate sensitivity.
- To elucidate the mechanism of homofolate-mediated growth inhibition.
Main Methods:
- Cell culture of L1210/JT-1 and parental L1210 cells.
- Growth inhibition assays with varying concentrations of homofolate, folate, and 5-formyltetrahydrofolate.
- Folate uptake studies using radiolabeled folate.
- Binding assays to determine homofolate affinity for folate binding protein and reduced-folate transport system.
Main Results:
- Homofolate caused significant growth inhibition of L1210/JT-1 cells at nanomolar concentrations.
- Inhibition correlated with homofolate's ability to block folate uptake via the high-affinity folate binding protein.
- Parental cells lacking the binding protein were resistant to homofolate.
- Homofolate exhibited high affinity for the folate binding protein but poor affinity for the reduced-folate transport system.
Conclusions:
- Homofolate inhibits L1210 cell growth specifically when folate uptake occurs through the high-affinity folate binding protein.
- The mechanism involves homofolate competing for substrate binding and internalization.
- This highlights the potential of targeting folate binding proteins for cancer therapy.